- Home
- OTTR vs RNA Comparison
OTTR vs RNA Comparison
Compare OTTR & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTTR
- RNA
- Stock Information
- Founded
- OTTR 1907
- RNA 2012
- Country
- OTTR United States
- RNA United States
- Employees
- OTTR N/A
- RNA N/A
- Industry
- OTTR Electric Utilities: Central
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- OTTR Utilities
- RNA Health Care
- Exchange
- OTTR Nasdaq
- RNA Nasdaq
- Market Cap
- OTTR 3.5B
- RNA 4.0B
- IPO Year
- OTTR N/A
- RNA 2020
- Fundamental
- Price
- OTTR $82.90
- RNA $39.90
- Analyst Decision
- OTTR
- RNA Strong Buy
- Analyst Count
- OTTR 0
- RNA 16
- Target Price
- OTTR N/A
- RNA $69.81
- AVG Volume (30 Days)
- OTTR 154.4K
- RNA 3.7M
- Earning Date
- OTTR 11-03-2025
- RNA 11-06-2025
- Dividend Yield
- OTTR 2.52%
- RNA N/A
- EPS Growth
- OTTR N/A
- RNA N/A
- EPS
- OTTR 6.79
- RNA N/A
- Revenue
- OTTR $1,311,540,000.00
- RNA $10,729,000.00
- Revenue This Year
- OTTR $0.94
- RNA N/A
- Revenue Next Year
- OTTR $4.69
- RNA $109.60
- P/E Ratio
- OTTR $12.26
- RNA N/A
- Revenue Growth
- OTTR N/A
- RNA 1.23
- 52 Week Low
- OTTR $71.66
- RNA $21.51
- 52 Week High
- OTTR $88.36
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- OTTR 50.72
- RNA 41.31
- Support Level
- OTTR $82.57
- RNA $39.83
- Resistance Level
- OTTR $84.75
- RNA $42.42
- Average True Range (ATR)
- OTTR 1.27
- RNA 2.80
- MACD
- OTTR -0.30
- RNA -1.24
- Stochastic Oscillator
- OTTR 23.78
- RNA 26.75
About OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.